Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts

被引:10
|
作者
Rellick, Stephanie L. [2 ]
Piktel, Debbie [2 ]
Walton, Cheryl [2 ]
Hall, Brett [4 ]
Petros, William
Fortney, James E. [2 ]
Gencheva, Marieta
Denvir, Jim [5 ]
Hobbs, Gerald [5 ]
Craig, Michael
Gibson, Laura F. [1 ,2 ,3 ]
机构
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA
[2] W Virginia Univ, Canc Cell Biol Program, Morgantown, WV 26506 USA
[3] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[5] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA
关键词
Interleukin-6; Melphalan; Bone marrow microenvironment; Osteoblast; Bone marrow stromal cell; HEMATOPOIETIC STEM-CELL; MULTIPLE-MYELOMA; GROWTH-FACTOR; EXPRESSION; ENDOTHELIUM; SECRETION; ADHESION; NICHES; LINES; MICE;
D O I
10.1016/j.cyto.2012.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow stromal cells (BMSC) and osteoblasts are critical components of the microenvironment that support hematopoietic recovery following bone marrow transplantation. Aggressive chemotherapy not only affects tumor cells, but also influences additional structural and functional components of the microenvironment. Successful reconstitution of hematopoiesis following stem cell or bone marrow transplantation after aggressive chemotherapy is dependent upon components of the microenvironment maintaining their supportive function. This includes secretion of soluble factors and expression of cellular adhesion molecules that impact on development of hematopoietic cells. In the current study, we investigated the effects of chemotherapy treatment on BMSC and human osteoblast (HOB) expression of interleukin-6 (IL-6) as one regulatory factor. IL-6 is a pleiotropic cytokine which has diverse effects on hematopoietic cell development. In the current study we demonstrate that exposure of BMSC or HOB to melphalan leads to decreases in IL-6 protein expression. Decreased IL-6 protein is the most pronounced following melphalan exposure compared to several other chemotherapeutic agents tested. We also observed that melphalan decreased IL-6 mRNA in both BMSC and HOB. Finally, using a model of BMSC or HOB co-cultured with myeloma cells exposed to melphalan, we observed that IL-6 protein was also decreased, consistent with treatment of adherent cells alone. Collectively, these observations are of dual significance. First, suggesting that chemotherapy induced IL-6 deficits in the bone marrow occur which may result in defective hematopoietic support of early progenitor cells. In contrast, the decrease in IL-6 protein may be a beneficial mechanism by which melphalan acts as a valuable therapeutic agent for treatment of multiple myeloma, where IL-6 present in the bone marrow acts as a proliferative factor and contributes to disease progression. Taken together, these data emphasize the responsiveness of the microenvironment to diverse stress that is important to consider in therapeutic settings. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [41] INTERLEUKIN-6 IS NOT INVOLVED IN THE INTERLEUKIN-1-INDUCED PRODUCTION OF COLONY-STIMULATING FACTORS BY HUMAN-BONE MARROW STROMAL CELLS AND FIBROBLASTS
    SCHAAFSMA, MR
    FIBBE, WE
    VANDAMME, J
    DUINKERKEN, N
    RALPH, P
    KAUSHANSKY, K
    ALTROCK, BW
    WILLEMZE, R
    FALKENBURG, JHF
    BLOOD, 1989, 74 (08) : 2619 - 2623
  • [42] Autocrine and Paracrine Interactions Between Multiple Myeloma Cells and Bone Marrow Stromal Cells By Growth Arrest-Specific Gene 6 Crosstalk with Interleukin-6
    Furukawa, Miki
    Hiroshi, Ohkawara
    Ogawa, Kazuei
    Ikeda, Kazuhiko
    Koki, Ueda
    Shichishima-Nakamura, Akiko
    Ito, Emi
    Imai, Jun-ichi
    Yanagisawa, Yuka
    Honma, Reiko
    Watanabe, Shinya
    Waguri, Satoshi
    Ikezoe, Takayuki
    Takeishi, Yasuchika
    BLOOD, 2016, 128 (22)
  • [43] HUMAN MARROW STROMAL CELLS - RESPONSE TO INTERLEUKIN-6 (IL-6) AND CONTROL OF IL-6 EXPRESSION
    NEMUNAITIS, J
    ANDREWS, DF
    MOCHIZUKI, DY
    LILLY, MB
    SINGER, JW
    BLOOD, 1989, 74 (06) : 1929 - 1935
  • [44] Orchiectomy Increases Bone Marrow Interleukin-6 Levels in Mice
    J. Zhang
    T. D. Pugh
    B. Stebler
    W. B. Ershler
    E. T. Keller
    Calcified Tissue International, 1998, 62 : 219 - 226
  • [45] Orchiectomy increases bone marrow interleukin-6 levels in mice
    Zhang, J
    Pugh, TD
    Stebler, B
    Ershler, WB
    Keller, ET
    CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (03) : 219 - 226
  • [46] Enhanced synthesis of interleukin-6, (IL-6) by normal human osteoblasts in response to CD34(+) hematopoietic bone marrow cells in vitro.
    Taichman, RS
    Reilly, MJ
    Verma, RS
    Emerson, SG
    BLOOD, 1996, 88 (10) : 2514 - 2514
  • [47] ADHESION OF HUMAN MYELOMA-DERIVED CELL-LINES TO BONE-MARROW STROMAL CELLS STIMULATES INTERLEUKIN-6 SECRETION
    UCHIYAMA, H
    BARUT, BA
    MOHRBACHER, AF
    CHAUHAN, D
    ANDERSON, KC
    BLOOD, 1993, 82 (12) : 3712 - 3720
  • [48] MULTIPLE BIOLOGICAL-ACTIVITIES ARE EXPRESSED BY A MOUSE INTERLEUKIN-6 CDNA CLONE ISOLATED FROM BONE-MARROW STROMAL CELLS
    CHIU, CP
    MOULDS, C
    COFFMAN, RL
    RENNICK, D
    LEE, F
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) : 7099 - 7103
  • [49] THE PRODUCTION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS IN APLASTIC-ANEMIA
    TANI, K
    OZAWA, K
    OGURA, H
    TAKAHASHI, S
    TAKAHASHI, K
    TSURUTA, T
    OKANO, A
    AKIYAMA, Y
    YOSHIKUBO, T
    SHIMANE, M
    ASANO, S
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 169 (04): : 325 - 334
  • [50] Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow
    Suwa, T
    Hogg, JC
    English, D
    Van Eeden, SF
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (06): : H2954 - H2960